Hack My Net Worth: How Can I Boost My Assets by $40,000?
When Money Gets in the Way of Major Life Decisions
The Right Ways to Split the Bill at a Restaurant
Study: Even Professional Investors Can't Beat the Market
Morning Market Losers
Benzinga's Top #PreMarket Losers
Gilead Sciences Buying Achillion Was Twitter Speculation at its Finest
Momo, Take-Two, Urban Outfitters Lead Monday's After-Hours Movers
Why Achillion Pharmaceuticals, Inc. Shares Soared Today
Monday's ETF Movers: PBE, ILF
Analyst Issues 5 Potential Biotech Buyout Candidates
Why Can't Gilead Run?
Dubious IP Makes Achillion Pharma A Stock To Avoid
Achillion Looks Less Risky After First-Quarter Earnings Beat